In this regard, Sandhu et al. have recently reported that methotrexate decreases the CD8+ IFNγ+ T cells population while marginally increases CD8+ IL17+ T cell population in rheumatoid arthritis patients. This evidence concerns the gene CD8A and rheumatoid arthritis.